Why This Promising Drug Will Be Pfizer's Next Blockbuster

[cafead]

via

• The medication could soon be approved to treat an addressable market of nearly 200,000 patients.
• Etrasimod, intended to treat ulcerative colitis, could haul in $1 billion in annual sales for Pfizer.
• The market is overly pessimistic about the eventual drop in Pfizer's coronavirus-related revenue

article source